In breast cancer cases, the status of 17βHSD1 immunoreactivity in carcinoma cells was reported to be significantly correlated with that of ER and PgR, suggesting that E2, synthesized by 17βHSD1 in carcinoma cells may act on these cells locally [18]. Here, ESR1 is linked to breast carcinoma.